rees that the reason they use addiction. Buprenorphine offers to science a
new tool to treat drug addicts and as thestudies presented a safer treatment. ReferencesHayley Pinto, Vivienne Maskrey, Louise Swift, Daphne Rumball, Ajay Wagle, Richard Holland.2010. The SUMMIT Trial:A field comparison of buprenorphine versus methadonemaintenance treatment. Available from Journal of Substance Abuse Treatment. July 2010.Judith Martin. 2006. Pregnancy and buprenorphine treatment. Available from PCSS Guidance athttp://www.naabt.org/documents/PCSSPregnancy.pdfLaurence Simmat-Durand, Claude Lejeune, Laurent Gourarier. 2009. 119-123: Pregnancy underhigh-dose buprenorphine. Available from European Journal of Obstetrics & Gynecology andReproductive Biology 142.Paola Sacerdote, Silvia Franchi, Gilberto Gerra, Vincenzo Leccese,Alberto E. Panerai, Lorenzo Somaini. 2008. 606-613:Buprenorphine and methadonemaintenance treatment of heroin addicts preserves immune function. Available fromwww.sciencedirect.comRolley E. Johnson, Paul J. Fudala, and Richard Payne. 2005. 297-326: Buprenorphine:Considerations for Pain Management. Available from Journal of Pain and SymptomManagement. Vol. 9 No. 3 March 2005.W. Mei, J. X. Zhang, and Z. Xiao. 2010. 808-815: Acute Effects of Sublingual buprenorphineon brain responses to heroin-related cues in early-abstinence heroin addicts: an uncontrolled trial.Available from Neuroscience 170 (2010).